Company news
Ardelyx, Inc. news in 2021
Ardelyx, Inc.'s news releases, calls and decks from 2021, newest first.
Ardelyx Launching IBSRELA® Second Quarter of 2022
November 29, 2021
Ardelyx Reports Third Quarter 2021 Financial Results
November 11, 2021
Ardelyx to Present at the Jefferies London Healthcare Conference
November 10, 2021
Ardelyx Reports Additional Positive Data Supporting Clinical Utility of Tenapanor at ASN's Kidney Week 2021
November 4, 2021
Ardelyx to Pursue Formal Dispute Resolution for Tenapanor
November 3, 2021
Ardelyx Announces Four Tenapanor Presentations at ASN's Kidney Week 2021
October 28, 2021
Ardelyx Provides Corporate Update Following Type A Meeting with FDA
October 12, 2021
Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial
September 2, 2021
Ardelyx Reports Second Quarter 2021 Financial Results
August 12, 2021
Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
July 28, 2021
Ardelyx Provides Regulatory Update on New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
July 18, 2021
Ardelyx Announces Presentations at ERA-EDTA Virtual Congress 2021
June 6, 2021
Ardelyx to Present at the Jefferies 2021 Virtual Healthcare Conference
May 24, 2021
Ardelyx Reports First Quarter 2021 Financial Results and Recent Business Highlights
May 5, 2021
Ardelyx Announces Extension of the PDUFA Review Period for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
April 28, 2021
Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 15, 2021
Ardelyx Collaboration Partner, Kyowa Kirin, Announces Initiation of Phase 3 Clinical Studies of Tenapanor for Hyperphosphatemia in Japan
April 13, 2021
Ardelyx Announces Upcoming Data Presentation at ISN World Congress of Nephrology 2021
April 11, 2021
Ardelyx Announces Poster Presentations, Educational Symposium, and Exhibitor Showcase at National Kidney Foundation 2021 Virtual Spring Clinical Meetings
March 29, 2021
Ardelyx Appoints Muna Bhanji, R.Ph, to its Board of Directors
March 14, 2021
Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
March 7, 2021
Ardelyx to Present at the 10th Annual SVB Leerink Global Healthcare Conference
February 16, 2021